CD24 and neoplasm: In this study, we employed the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/Cas9 genome-editing technique to knock out the Cd24a gene in 4T1 cells, a murine cell line of TNBC, and this allowed us to investigate the role of CD24a in tumor-immune dynamics.